PURE EXTRACTS TECH CORP - PRXTF STOCK NEWS

Pure Extracts Technologies Corp. (OTC: PRXTF) has signed a Letter of Intent to establish a Joint Venture with a multi-state operator (MSO) to install a cannabis and hemp extraction system in Michigan. The JV aims to leverage the MSO's local market expertise and Pure Extracts' manufacturing capabilities to meet the rising demand for cannabis concentrates and edibles. Michigan's cannabis sales surged 160% year-over-year to $106.2 million in February 2021. The venture plans to utilize underused space in the MSO's facility to rapidly scale operations.

Pure Extracts Technologies Corp (OTC: PRXTF) has signed a Letter of Intent to form a Joint Venture with a multi-state operator in Michigan to install a cannabis extraction system. The venture will utilize 2,600 sq. ft. of space in the MSO’s facility, enabling rapid scaling to meet increasing demand for cannabis concentrates and edibles in Michigan. The market has shown significant growth, with cannabis sales in February 2021 reaching $106.2 million. Pure Extracts anticipates distribution of its products to over 100 dispensaries by Q4 2021.

Pure Extracts Technologies Corp (CSE: PULL) (OTC: PRXTF) has announced the acquisition of a revolutionary Cosolvent Injection System from Vitalis Extraction Technology Inc. This system aims to enhance throughput capacities and improve the quality of cannabis extracts, leveraging optimal ethanol co-solvent flow rates. CEO Ben Nikolaevsky highlighted that this advancement will enable faster production and exceptional value for customers. The company's facility operates under E.U. GMP standards, and it holds a processing license from Health Canada.

Pure Extracts Technologies Corp. (CSE: PULL, OTC: PRXTF) has announced that its subsidiary, Pure Mushrooms Corp., has ordered its first shipment of functional mushrooms. The company has developed three premium formulations available in vegan capsules, with sales expected to start in April and June for different products. Each formulation has the potential to generate $15,000 in gross sales monthly. The CEO emphasizes market growth due to increased consumer interest in health supplements amid the COVID-19 pandemic, while the company continues to expand its extraction facility.

Pure Extracts Technologies Corp (CSE: PULL, OTC: PRXTF) announced its first sale of cannabis oil extracts to a German pharmaceutical company. The extracts, consisting of 65% pure THC full spectrum oil and 85% pure THC distillate, were derived from EU-GMP certified cannabis. This initial transaction aims to establish longer-term supply agreements in Germany, a key European market, and supports continued expansion into other European countries. CEO Ben Nikolaevsky expressed optimism about the opportunities in the European market for their products.

Pure Extracts Technologies Corp. (OTC: PRXTF) announced a Letter of Intent (LOI) with ShroomBloom Labs for supply of psychedelic mushroom biomass. The agreement allows Pure Extracts preferential access to high-potency psychedelic mushrooms, specifically Psilocybe Azurescens, which contains up to 1.8% psilocybin. This arrangement is pending both companies obtaining Dealer's Licences. CEO Ben Nikolaevsky emphasized the importance of securing this biomass for their extraction facility and future clinical trials. Pure Extracts is focused on cannabis, hemp, and the psychedelic sector.

Pure Extracts Technologies Corp. (CSE: PULL, OTC: PRXTF) has announced that its subsidiary, Pure Mushrooms Corp., has applied for a Dealer’s Licence with Health Canada under the Controlled Drugs and Substances Act (CDSA). This licence will allow the company to conduct various activities related to controlled substances, including psilocybin extraction. CEO Ben Nikolaevsky emphasized the importance of this step for future partnerships with medical and pharmaceutical entities. The company aims to pave the way for legal psychedelic extracts and micro-dosing applications in the future.

Pure Extracts Technologies Corp (OTC: PRXTF) announced that its subsidiary has ordered over 30,000 vape cartridges and pens for the Canadian market, expected by early April. These products meet North American standards and will be filled with proprietary full spectrum oil formulations. Revenue from this shipment is estimated at $650,000. The company is preparing for a retail launch and has submitted over 20 product SKUs to Health Canada for approval. CEO Ben Nikolaevsky highlighted the importance of this inventory build for provincial distribution channels.

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) has announced a significant order of over 30,000 vape cartridges and pens for the Canadian market, expected to generate approximately $650,000 in revenue. These products adhere to North American standards and will arrive in early April, coinciding with the company's retail distribution agreement. Pure Extracts is also preparing to launch its Pure Chews brand of CBD and THC edible gummies, showcasing a strong demand for concentrates in targeted provinces.